Delayed post-COVID-19 hemophagocytic lymphohistiocytosis in patient with XIAP deficiency

Pediatr Allergy Immunol. 2023 Sep;34(9):e14028. doi: 10.1111/pai.14028.

Authors

Jonathan H Chen¹, Talia Arceri², Rahul Datta², Kathleen E Sullivan²

Affiliations

¹ Department of Internal Medicine, Lankenau Medical Center, Main Line Health, Wynnewood, Pennsylvania, USA.
² Division of Allergy and Immunology, Department of Pediatrics, Perelman School of Medicine, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

PMID: 37747746
DOI: 10.1111/pai.14028

No abstract available

Publication types

Case Reports
Letter

MeSH terms

COVID-19* / complications
Genetic Diseases, X-Linked*
Humans
Lymphohistiocytosis, Hemophagocytic* / diagnosis
Lymphoproliferative Disorders*
X-Linked Inhibitor of Apoptosis Protein

Substances

X-Linked Inhibitor of Apoptosis Protein
XIAP protein, human

Supplementary concepts

Lymphoproliferative Syndrome, X-Linked, 2